PlainPharmaWatch

CMS Open Payments · Program Year 2024

Colorado

Colorado received $63,417,339.13 in pharmaceutical-industry payments to 11,791 physicians and 21 teaching hospitals across 209,421 transactions.

$63.4M
Total payments
$47.3M
To physicians
$11.4M
To teaching hospitals
#17
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $63.4M in payments to 11,791 physicians and 21 teaching hospitals in Colorado. That ranks Colorado #17 of 59 states and territories (0.5% of the US total), averaging $4.0K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Colorado pairs above-median payment volume with a physician-heavy payment mix.

#17
of 59 states
0.5%
of the national total
74.5%
to physicians vs. hospitals
11,791
physicians paid

What the Data Shows for Colorado

Colorado's Open Payments file is hospital-weighted: 18.0% of $63.4M went to 21 teaching hospitals ($542.8K each), with 74.5% on 11,791 physicians.

On the national dollar ranking it is still #17 of 59 (0.5% of US payments). Average transaction $302.82. Leading nature of payment: "Royalty or License" at $16.7M (26.3% of the state file; top-three natures 71.4%).

Colorado sits in the 73rd percentile (mid-pack). Just above: New Jersey ($64.8M). Just below: Washington ($59.1M). For context: top-ranked California ($342.4M) is 5.4× larger than Colorado. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Colorado are distributed between physicians and teaching hospitals.

Physician Payments

$47.3M

74.5% of total · 11,791 recipients · $4.0K avg

Teaching Hospital Payments

$11.4M

18.0% of total · 21 hospitals · $542.8K avg

Payment Breakdown by Type

Colorado has 15 types of pharmaceutical payments. "Royalty or License" accounts for 26.3%.

Nature concentration in Colorado

Top three Open Payments natures are 71.4% of state dollars; residual is every other reported nature

Royalty or License$16.7MCompensation for Services Ot…$14.4MConsulting Fee$14.2MAll other natures (12)$18.1M

Payment categories in Colorado

Top categories by total reported dollar volume

1. Royalty or License$16.7M2. Compensation for Services…$14.4M3. Consulting Fee$14.2M4. Food and Beverage$5.9M5. Grant$4.1M6. Travel and Lodging$4.1M7. Education$1.2M8. Long-Term Medical Supply …$655.5K9. Honoraria$573.8K10. Space Rental or Facility…$503.8K
Payment Type Amount Transactions
Royalty or License $16.7M 483
Compensation for Services Other Than Consulting $14.4M 4,632
Consulting Fee $14.2M 4,308
Food and Beverage $5.9M 183,025
Grant $4.1M 123
Travel and Lodging $4.1M 12,361
Education $1.2M 2,540
Long-Term Medical Supply or Device Loan $655.5K 183
Honoraria $573.8K 339
Space Rental or Facility Fees $503.8K 133
Compensation for Faculty or Speaker (Medical Education) $474.1K 292
Acquisitions $349.2K 30
Gift $166.2K 781
Debt Forgiveness $146.2K 60
Entertainment $11.1K 131

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Colorado totals can and cannot tell you

The aggregate payment figure for Colorado measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Colorado's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.